Sponsor or institution
Clinical trials and research at Lomond Therapeutics Holdings, Inc.
As of November 12, 2026, Find a Trial lists 3 clinical trials run by Lomond Therapeutics Holdings, Inc. that are recruiting, at sites in 6 countries (most in United States (2), Russia (1), Uzbekistan (1)). By phase: Phase 1 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 6Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Lonitoclax and Azacitidine in Relapsed/Refractory AML | Phase 1 | Moscow, Moscow and 5 other locations | Recruiting | Dec 26, 2025 |
| ZE50-0134 for relapsed or refractory CLL, SLL, and select low-grade lymphomas | Phase 1 | Louisville, Kentucky and 4 other locations | Recruiting | Nov 27, 2024 |
| Dose escalation and expansion of ZE46-0134 for adults with FLT3‑mutated or spliceosome‑mutated relapsed or refractory acute myeloid leukemia. | Phase 1 | Los Angeles, California and 22 other locations | Recruiting | Apr 16, 2024 |
All recruiting trials (3)
-
Lonitoclax and Azacitidine in Relapsed/Refractory AML
This study tests whether combining Lonitoclax with Azacitidine is safe and shows early signs of activity in adults with relapsed or refractory acute myeloid leukemia.
-
ZE50-0134 for relapsed or refractory CLL, SLL, and select low-grade lymphomas
This study tests whether a new drug called ZE50-0134 is safe and has anti-lymphoma activity in adults with relapsed or refractory chronic lymphocytic leukemia, small lymphocytic lymphoma, or certain low-grade lymphomas.
-
Dose escalation and expansion of ZE46-0134 for adults with FLT3‑mutated or spliceosome‑mutated relapsed or refractory acute myeloid leukemia.
This trial tests whether ZE46-0134 is safe and can help adults with relapsed or refractory AML who have FLT3 or spliceosome gene mutations.
Quick answers
How many clinical trials run by Lomond Therapeutics Holdings, Inc. are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in United States (2 trials), Russia (1 trial), Uzbekistan (1 trial), Australia (1 trial), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.